Skip to content

Opening book details…

Can I read Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval on EtoBox?

Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval by Namik Delibas; Ramazan Ozcankaya; Irfan Altuntas is a Medicine article available to read on EtoBox.

What is Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval about?

## Objectives: The aim of the present study was to determine the effects of aging and dementia of the Alzheimer type (DAT) on lipid peroxidation and antioxidant enzyme activities. Design and methods: Twenty-six patients with DAT were included in the present study. Group I: 26 patients diagnosed as DAT and studied 5 yr ago. Group II: This group consisted of the same patients as Group I at the present time. Activities of CuZn superoxide dismutase (CuZn SOD) and glutathione peroxidase (GSH-Px) and malondialdehyde (MDA) concentrations of these 26 subjects were measured and mini mental state examination (MMSE), brief psychiatric rating scale (BPRS), Hamilton depression rating scale (HDRS) were applied. ## Results: The results revealed that 26 dementia patients had worsened cognitive symptoms and significantly increased CuZn SOD and MDA levels and decreased GSH-Px levels after 5 yr. Significant correlation was found between age and CuZn SOD (r: ϩ0.406, p: 0.034), and between MMSE and MDA (r: Ϫ0.411, p: 0.032). ## Conclusions: We can conclude that MDA, CuZn SOD, and GSH-Px were significantly affected in the patients with Alzheimer disease. The most striking finding of this study is the si

Who reads Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Namik Delibas; Ramazan Ozcankaya; Irfan Altuntas
Publisher
Elsevier Science; Elsevier ; Elsevier BV (ISSN 0009-9120)
Published
2002
Language
EN
Field
Medicine (Health Sciences)

More by Namik Delibas; Ramazan Ozcankaya; Irfan Altuntas

Browse all works by Namik Delibas; Ramazan Ozcankaya; Irfan Altuntas